We are pleased to share that our 2022 Annual Report has been lodged with the ASX: https://imagionbiosystems.com/news/2022-annual-report/
2023 is expected to be an exciting year as we advance our pipeline of MagSense imaging agents for the earlier and better detection of cancer.
We look forward to increased momentum as we aim to change the way we look at cancer.
- Forums
- ASX - By Stock
- Ann: 2022 Annual Report to Shareholders
We are pleased to share that our 2022 Annual Report has been...
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
-0.002(2.44%) |
Mkt cap ! $2.612M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 8.0¢ | $10.55K | 131.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3574 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 9000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3344 | 0.080 |
1 | 9608 | 0.077 |
1 | 13155 | 0.076 |
2 | 32500 | 0.075 |
2 | 50000 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 251 | 1 |
0.082 | 15081 | 2 |
0.086 | 9193 | 1 |
0.087 | 1250 | 1 |
0.088 | 4862 | 1 |
Last trade - 12.00pm 26/06/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |